Q3 2021 13F Holders as of 9/30/2021
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
56M
-
Number of holders
-
217
-
Total 13F shares, excl. options
-
54.4M
-
Shares change
-
+154K
-
Total reported value, excl. options
-
$1.45B
-
Value change
-
+$2.48M
-
Put/Call ratio
-
0.12
-
Number of buys
-
105
-
Number of sells
-
-103
-
Price
-
$26.67
Significant Holders of SUPERNUS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share (SUPN) as of Q3 2021
263 filings reported holding SUPN - SUPERNUS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share as of Q3 2021.
SUPERNUS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share (SUPN) has 217 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 54.4M shares
of 56M outstanding shares and own 97.12% of the company stock.
Largest 10 shareholders include BlackRock Inc. (8.86M shares), VANGUARD GROUP INC (5.48M shares), ARMISTICE CAPITAL, LLC (3.9M shares), DIMENSIONAL FUND ADVISORS LP (2.28M shares), MACQUARIE GROUP LTD (2.14M shares), STATE STREET CORP (1.83M shares), LOOMIS SAYLES & CO L P (1.65M shares), GW&K Investment Management, LLC (1.63M shares), RENAISSANCE TECHNOLOGIES LLC (1.39M shares), and Aristotle Capital Boston, LLC (1.32M shares).
This table shows the top 217 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.